OnKure logo

OnKure Funding & Investors

Boulder, CO

OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancer.

onkuretherapeutics.com

Total Amount Raised: $186,493,872

OnKure Funding Rounds

  • Post Ipo Equity

    $65,000,000

    Post Ipo Equity Investors

    Surveyor Capital
    Samsara BioCapital
    Acorn Bioventures
    Deep Track Capital
    Vestal Point Capital
    Cormorant Asset Management
    Perceptive Advisors
  • Series C

    $54,000,000

    Series C Investors

    Surveyor Capital
    Acorn Bioventures
    Cormorant Asset Management
    Perceptive Advisors
    Deep Track Capital
    Samsara BioCapital
    BlackRock
  • Series B

    $56,649,181

    Series B Investors

    Acorn Bioventures
    Cormorant Asset Management
    Perceptive Advisors
    Samsara BioCapital
    Surveyor Capital
  • IPO

    Unknown

  • Debt Financing

    $2,000,000

  • Series A

    $7,000,000

    Series A Investors

    Delian Capital
    OnKure management
  • Seed

    $495,000

  • Seed

    $599,705

  • Grant

    $250,000

  • Pre Seed

    $499,985

Funding info provided by Diffbot.